Skip to main content

SkinHealth Systems Inc.

corporate_fare Company Profile

SkinHealth Systems Inc.

SKIN·NASDAQ·Industrial Applications And Services·CIK 0001818093

The Beauty Health Company is a global medical aesthetics company that provides clinically proven solutions for skin health and supports healthcare providers. The company's core offering is Hydrafacial, a professional skincare treatment, complemented by SkinStylus microneedling and HydraScalp powered by Keravive. The Beauty Health Company integrates advanced device technology, proprietary consumable products, and clinical validation to deliver treatments through a worldwide network of providers. Hydrafacial is the company's primary brand and created the hydradermabrasion category. It uses a patented delivery system to cleanse, extract, and hydrate the skin with proprietary solutions and serums. The HydraScalp powered by Keravive treatment, an extension of Hydrafacial, cleanses, exfoliates, and hydrates the scalp and hair follicles to support natural hair growth and improve the appearance of healthier, thicker, fuller-looking hair. SkinStylus specializes in nano-channeling and microneedling products, offering non-invasive or minimally-invasive skin treatments. The main Hydrafacial product is the Syndeo device, which is the current generation of its delivery system, along with its associated serum solutions and consumables. The Syndeo device is classified as a Class I exempt medical device by the U.S. Food and Drug Administration (FDA). Syndeo features updated hardware and software, including Wi-Fi connectivity and radio frequency identification, which enable data collection to personalize skincare experiences. Predecessor models of the Hydrafacial delivery system include the Elite Tower and the Allegro.

SkinHealth Systems Inc. (NASDAQ:SKIN) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 23 items for SKIN at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-05, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 10 rated 8 or above. Recent SEC coverage for SKIN spans 10-Q, 8-K, DEF 14A, PRE 14A.

Recent high-impact activity:

  • SkinHealth Q3: Net Loss Narrows to $0.9M, But $250M 2028 Notes Need Refinancing
  • SkinHealth Q3 Sales Slip 2.1% to $69.2M, Adjusted EBITDA Jumps to $13.4M
  • Q3 Sales Slip 2.1% but Adjusted EBITDA Jumps to $13.4M; Guidance Reaffirmed
  • SkinHealth Repays $103.2M Convertible Notes, Eliminating $353M Repurchase Crisis
  • SkinHealth Sets Sept 22 Vote on 1-for-5 to 1-for-20 Reverse Split to Avoid Nasdaq Delisting

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$300.79M
Net Income
-$9.52M
Diluted EPS
-$0.16
Op. Cash Flow
$37.48M
Free Cash Flow
$37.18M
Gross Profit
$196.36M
Operating Income
-$20.8M
Cash & Equivalents
$232.67M
Total Debt
$240.43M
Debt / Equity
3.94×
Net Margin
-3.2%
Shares Outstanding
127.52M sh
Source: 10-K · filed 2026-03-12 · accession 0001628280-26-017376

Short Interest & Short Volume

6.69 days to cover

FINRA reported short interest of 358,652 shares in SKIN as of the October 30, 2026 settlement, a 4.5% decrease from the prior period — about 6.7 days to cover at its recent average daily volume. On November 13, 2026, 18.5% of SKIN volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)358,652 shares as of October 30, 2026
Change vs prior period▼ 4.5%
Days to cover6.69 at avg daily volume of 53,625
Daily short volume (FINRA facilities)18.5% of 35,130 shares on November 13, 2026
5-day average short volume18.7%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with S →
$16.31
52-week range · as of 2026-11-05 $9.68 – $34.8
Market cap
$106.71M
Volume
86.3K (1.4× avg)
3-mo avg 62.1K
Live data · 2026-11-15 17:44 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed SKIN - Latest Insights

SKIN
Nov 05, 2026, 5:16 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $10.35
Real-time Price: $16.31 info
Change: +$5.96 (+58%) info
Market Cap: $106.708M info
SKIN
Nov 05, 2026, 4:13 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $10.35
Real-time Price: $16.31 info
Change: +$5.96 (+58%) info
Market Cap: $106.708M info
SKIN
Nov 05, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $10.35
Real-time Price: $16.31 info
Change: +$5.96 (+58%) info
Market Cap: $106.708M info
SKIN
Oct 06, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.586
Real-time Price: $16.31 info
Change: Reverse Stock Split info
Market Cap: $106.708M info
SKIN
Aug 12, 2026, 4:05 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $0.6468
Real-time Price: $16.31 info
Change: Reverse Stock Split info
Market Cap: $106.708M info
SKIN
Aug 06, 2026, 5:17 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.693
Real-time Price: $16.31 info
Change: Reverse Stock Split info
Market Cap: $106.708M info
SKIN
Aug 06, 2026, 4:43 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $0.677
Real-time Price: $16.31 info
Change: Reverse Stock Split info
Market Cap: $106.708M info
SKIN
Aug 06, 2026, 4:11 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.6776
Real-time Price: $16.31 info
Change: Reverse Stock Split info
Market Cap: $106.708M info
SKIN
Jul 31, 2026, 4:05 PM EDT
Filing Type: PRE 14A
Importance Score:
9
Price at Filing: $0.6855
Real-time Price: $16.31 info
Change: Reverse Stock Split info
Market Cap: $106.708M info
SKIN
Jul 07, 2026, 8:05 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.7794
Real-time Price: $16.31 info
Change: Reverse Stock Split info
Market Cap: $106.708M info
SKIN
Jun 22, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.6719
Real-time Price: $16.31 info
Change: Reverse Stock Split info
Market Cap: $106.708M info
SKIN
May 21, 2026, 4:40 PM EDT
Filing Type: 8-K/A
Importance Score:
7
Price at Filing: $0.6599
Real-time Price: $16.31 info
Change: Reverse Stock Split info
Market Cap: $106.708M info
SKIN
May 20, 2026, 4:25 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $0.6775
Real-time Price: $16.31 info
Change: Reverse Stock Split info
Market Cap: $106.708M info
SKIN
May 12, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.6546
Real-time Price: $16.31 info
Change: Reverse Stock Split info
Market Cap: $106.708M info
SKIN
May 07, 2026, 5:16 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $0.830
Real-time Price: $16.31 info
Change: Reverse Stock Split info
Market Cap: $106.708M info
SKIN
May 07, 2026, 4:13 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $0.8161
Real-time Price: $16.31 info
Change: Reverse Stock Split info
Market Cap: $106.708M info
SKIN
May 07, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.830
Real-time Price: $16.31 info
Change: Reverse Stock Split info
Market Cap: $106.708M info
SKIN
May 06, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.9327
Real-time Price: $16.31 info
Change: Reverse Stock Split info
Market Cap: $106.708M info
SKIN
Apr 22, 2026, 4:13 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.9115
Real-time Price: $16.31 info
Change: Reverse Stock Split info
Market Cap: $106.708M info
SKIN
Mar 12, 2026, 5:35 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $1.05
Real-time Price: $16.31 info
Change: Reverse Stock Split info
Market Cap: $106.708M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets